Clinical Trial Update: EVeRLAST 2-Year Follow-Up

View source ↗

Summary

2-year follow-up results from the EVeRLAST trial in pelvic organ prolapse have been completed and updates are available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Snippet

Sponsor: Duke University | Conditions: Pelvic Organ Prolapse | Status: COMPLETED